• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

青光眼患者泪液中基质金属蛋白酶2和9的功能活性

Functional Activity of Matrix Metalloproteinases 2 and 9 in Tears of Patients With Glaucoma.

作者信息

Sahay Prity, Rao Aparna, Padhy Debananda, Sarangi Sarada, Das Gopinath, Reddy Mamatha M, Modak Rahul

机构信息

Hyderabad Eye Research Foundation (HERF), LV Prasad Eye Institute, Patia, Bhubaneswar, Odisha, India 2KIIT School of Biotechnology, Patia, Bhubaneswar, Odisha, India.

Hyderabad Eye Research Foundation (HERF), LV Prasad Eye Institute, Patia, Bhubaneswar, Odisha, India.

出版信息

Invest Ophthalmol Vis Sci. 2017 May 1;58(6):BIO106-BIO113. doi: 10.1167/iovs.17-21723.

DOI:10.1167/iovs.17-21723
PMID:28586796
Abstract

PURPOSE

To evaluate the differential expression of tear matrix metalloproteinases (MMP) 2 and 9 in of patients with various forms of glaucoma.

METHODS

Tear samples were collected with a Schirmer's strip from 148 eyes of 113 patients (medically naïve patients with primary open-angle [POAG] or angle closure glaucoma [PACG] and those with pseudoexfoliation syndrome [PXF] or glaucoma [PXG]). These were compared to patients undergoing cataract surgery (controls) for this cross-sectional study. Functional activities of tear MMP-9 and MMP-2 were analyzed by gelatin zymography. Tenon's capsules (n = 15) were harvested from the inferior quadrant in those undergoing cataract surgery and protein expression of MMP-9 was analyzed by immunohistochemistry (IHC). Hydrogen peroxide (H2O2) stress-induced effects on in vitro activities of MMP-9 in human trabecular meshwork (HTM) cells were analyzed.

RESULTS

The MMP-9 activity in tears was increased significantly in POAG, (n = 27), PACG (n = 24), and PXF (n = 40) eyes compared to controls (n = 35), and was increased significantly in eyes with glaucoma compared to moderate/severe glaucoma (P < 0.001). The MMP-9 expression was significantly lower in PXG (n = 22) eyes. Immunohistochemistry of Tenon's capsule revealed increased expression of MMP-9 in primary glaucoma eyes. Increased MMP-9 activity was seen in in vitro by gelatin zymography and was confirmed by Western and immunofluorescent assay on HTM upon 800 and 1000 μM H2O2-induced stress for 2 to 3 hours with approximately 80% cell death.

CONCLUSIONS

Increased tear MMP-9 activity in early glaucoma and pseudoexfoliation syndrome suggesting activation of extracellular matrix (ECM) degradation can be used as a tear-based predictive biomarker. Decreased expression in advanced stages suggests exhaustion of the degradation response.

摘要

目的

评估不同类型青光眼患者泪液中基质金属蛋白酶(MMP)2和9的差异表达。

方法

采用泪液试纸从113例患者的148只眼中收集泪液样本(未经治疗的原发性开角型青光眼[POAG]或闭角型青光眼[PACG]患者以及假性剥脱综合征[PXF]或剥脱性青光眼[PXG]患者)。在这项横断面研究中,将这些患者与接受白内障手术的患者(对照组)进行比较。通过明胶酶谱法分析泪液MMP - 9和MMP - 2的功能活性。从接受白内障手术患者的下象限采集15个眼球筋膜囊,通过免疫组织化学(IHC)分析MMP - 9的蛋白表达。分析过氧化氢(H2O2)应激对人小梁网(HTM)细胞中MMP - 9体外活性的影响。

结果

与对照组(n = 35)相比,POAG组(n = 27)、PACG组(n = 二十四)和PXF组(n = 40)眼中泪液中的MMP - 9活性显著增加,与中度/重度青光眼相比,青光眼患者眼中的MMP - 9活性显著增加(P < 0.001)。PXG组(n = 22)眼中的MMP - 9表达显著降低。眼球筋膜囊的免疫组织化学显示原发性青光眼眼中MMP - 9表达增加。通过明胶酶谱法在体外观察到MMP - 9活性增加,并通过Western和免疫荧光分析在800和1000μM H2O2诱导应激2至3小时后对HTM进行确认,此时细胞死亡率约为80%。

结论

早期青光眼和假性剥脱综合征中泪液MMP - 9活性增加,提示细胞外基质(ECM)降解激活,可作为基于泪液的预测生物标志物。晚期表达降低提示降解反应耗竭。

相似文献

1
Functional Activity of Matrix Metalloproteinases 2 and 9 in Tears of Patients With Glaucoma.青光眼患者泪液中基质金属蛋白酶2和9的功能活性
Invest Ophthalmol Vis Sci. 2017 May 1;58(6):BIO106-BIO113. doi: 10.1167/iovs.17-21723.
2
Differences in the histopathology and matrix metalloproteinase expression in Tenon's tissue of primary open-angle glaucoma and primary angle-closure glaucoma.原发性开角型青光眼和原发性闭角型青光眼巩膜囊下组织的组织病理学及基质金属蛋白酶表达差异
Korean J Ophthalmol. 2008 Mar;22(1):37-42. doi: 10.3341/kjo.2008.22.1.37.
3
TGFβ1, MMPs and cytokines profiles in ocular surface: Possible tear biomarkers for pseudoexfoliation.眼表中的转化生长因子β1、基质金属蛋白酶和细胞因子谱:假性剥脱可能的泪液生物标志物。
PLoS One. 2021 Apr 29;16(4):e0249759. doi: 10.1371/journal.pone.0249759. eCollection 2021.
4
MMP expression in leaking filtering blebs and tears after glaucoma filtering surgery.青光眼滤过手术后渗漏滤过泡和溢泪中的 MMP 表达。
Graefes Arch Clin Exp Ophthalmol. 2011 Jul;249(7):1047-55. doi: 10.1007/s00417-011-1658-0. Epub 2011 Mar 31.
5
Matrix metalloproteinases and tissue inhibitors of metalloproteinases in the aqueous humour of patients with primary angle closure glaucoma - a quantitative study.原发性闭角型青光眼患者房水中的基质金属蛋白酶和金属蛋白酶组织抑制剂 - 一项定量研究。
BMC Ophthalmol. 2014 Mar 24;14:33. doi: 10.1186/1471-2415-14-33.
6
Matrix metalloproteinases and their inhibitors in the chamber angle of normal eyes and patients with primary open-angle glaucoma and exfoliation glaucoma.正常眼、原发性开角型青光眼和剥脱性青光眼患者房角中的基质金属蛋白酶及其抑制剂
Graefes Arch Clin Exp Ophthalmol. 2007 May;245(5):697-704. doi: 10.1007/s00417-006-0440-1. Epub 2006 Oct 7.
7
Tear biomarkers in latanoprost and bimatoprost treated eyes.前列腺素类药物和贝美前列素治疗眼的泪液生物标志物。
PLoS One. 2018 Aug 6;13(8):e0201740. doi: 10.1371/journal.pone.0201740. eCollection 2018.
8
Matrix metalloproteinases and their tissue inhibitors in aqueous humor of patients with primary open-angle glaucoma, exfoliation syndrome, and exfoliation glaucoma.原发性开角型青光眼、剥脱综合征和剥脱性青光眼患者房水中的基质金属蛋白酶及其组织抑制剂
J Glaucoma. 2005 Feb;14(1):64-9. doi: 10.1097/01.ijg.0000145812.39224.0a.
9
Hyaluronic acid increases MMP-2 and MMP-9 expressions in cultured trabecular meshwork cells from patients with primary open-angle glaucoma.透明质酸可增加原发性开角型青光眼患者培养的小梁网细胞中MMP - 2和MMP - 9的表达。
Mol Vis. 2012;18:1175-81. Epub 2012 May 4.
10
Contributions of ocular surface components to matrix-metalloproteinases (MMP)-2 and MMP-9 in feline tears following corneal epithelial wounding.眼表成分对角膜上皮损伤后猫泪液中基质金属蛋白酶(MMP)-2 和 MMP-9 的影响。
PLoS One. 2013 Aug 19;8(8):e71948. doi: 10.1371/journal.pone.0071948. eCollection 2013.

引用本文的文献

1
The impact of matrix metalloproteinases and their tissue inhibitors in patients with chronic glaucoma - a literature review.基质金属蛋白酶及其组织抑制剂在慢性青光眼患者中的作用——文献综述
Rom J Morphol Embryol. 2024 Oct-Dec;65(4):557-565. doi: 10.47162/RJME.65.4.01.
2
A bibliometric and visualization analysis of electrochemical biosensors for early diagnosis of eye diseases.用于眼部疾病早期诊断的电化学生物传感器的文献计量与可视化分析
Front Med (Lausanne). 2025 Jan 10;11:1487981. doi: 10.3389/fmed.2024.1487981. eCollection 2024.
3
Smart Contact Lenses in Ophthalmology: Innovations, Applications, and Future Prospects.
眼科中的智能隐形眼镜:创新、应用与未来前景。
Micromachines (Basel). 2024 Jun 30;15(7):856. doi: 10.3390/mi15070856.
4
Advancements in Wearable and Implantable Intraocular Pressure Biosensors for Ophthalmology: A Comprehensive Review.眼科可穿戴和植入式眼压生物传感器的进展:全面综述
Micromachines (Basel). 2023 Oct 9;14(10):1915. doi: 10.3390/mi14101915.
5
New Biomarker Combination Related to Oxidative Stress and Inflammation in Primary Open-Angle Glaucoma.与原发性开角型青光眼氧化应激和炎症相关的新型生物标志物组合
Life (Basel). 2023 Jun 27;13(7):1455. doi: 10.3390/life13071455.
6
Aqueous Humor Cytokine Profile in Primary Congenital Glaucoma.原发性先天性青光眼房水细胞因子谱
J Clin Med. 2023 Apr 26;12(9):3142. doi: 10.3390/jcm12093142.
7
Tear nanoDSF Denaturation Profile Is Predictive of Glaucoma.眼液纳流分散谱变性分析可预测青光眼。
Int J Mol Sci. 2023 Apr 12;24(8):7132. doi: 10.3390/ijms24087132.
8
Changes in Tear Proteomic Profile in Ocular Diseases.眼疾相关泪液蛋白质组特征的变化。
Int J Environ Res Public Health. 2022 Oct 16;19(20):13341. doi: 10.3390/ijerph192013341.
9
PBX1 attenuates HO-induced oxidant stress in human trabecular meshwork cells via promoting NANOG-mediated PI3K/AKT signaling pathway. PBX1 通过促进 NANOG 介导的 PI3K/AKT 信号通路减弱 HO 诱导的人眼小梁细胞中的氧化应激。
Cell Stress Chaperones. 2022 Nov;27(6):673-684. doi: 10.1007/s12192-022-01304-x. Epub 2022 Oct 18.
10
Tear Biomarkers in Alzheimer's and Parkinson's Diseases, and Multiple Sclerosis: Implications for Diagnosis (Systematic Review).阿尔茨海默病、帕金森病和多发性硬化症的泪液生物标志物:对诊断的影响(系统评价)。
Int J Mol Sci. 2022 Sep 4;23(17):10123. doi: 10.3390/ijms231710123.